Beijing Scitop Bio-tech Co., Ltd. (SHE:300858)
23.45
+0.21 (0.90%)
Apr 21, 2026, 3:09 PM CST
Beijing Scitop Bio-tech Market Cap
Beijing Scitop Bio-tech has a market cap or net worth of 6.18 billion as of April 21, 2026. Its market cap has increased by 82.63% in one year.
Market Cap
6.18B
Enterprise Value
5.37B
Revenue
351.47M
Ranking
n/a
PE Ratio
61.69
Stock Price
23.45
Market Cap Chart
Since July 27, 2020, Beijing Scitop Bio-tech's market cap has increased from 2.82B to 6.18B, an increase of 119.40%. That is a compound annual growth rate of 14.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 6.12B | 38.58% |
| Dec 31, 2025 | 4.42B | 16.62% |
| Dec 31, 2024 | 3.79B | -25.49% |
| Dec 29, 2023 | 5.09B | 10.44% |
| Dec 30, 2022 | 4.60B | -6.62% |
| Dec 31, 2021 | 4.93B | -1.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Vazyme Biotech | 7.50B |
| Shanghai OPM Biosciences | 7.26B |
| Wuhan Keqian Biology Co.,Ltd | 7.01B |
| Anhui Huaheng Biotechnology | 7.00B |
| Xiangxue Pharmaceutical | 6.83B |
| R&G PharmaStudies | 6.50B |
| Lifecome Biochemistry | 6.31B |
| Kexing Biopharm | 6.27B |